Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Gabapentinoide

Pregabalin (Lyrica): findings of safety study on risks during pregnancy 

Pregabalin (Lyrica): findings of safety study on risks during pregnancy 

A new study has suggested pregabalin may slightly increase the risk of major congenital malformations if used in pregnancy. Patients should continue to use effective contraception during treatment and avoid use in pregnancy unless clearly necessary. (gov.uk, UK, 19.04.2022)

https://www.gov.uk/drug-safety-update/pregabalin-lyrica-findings-of-safety-study-on-risks-during-pregnancy